Genetic Analysis

Ivan Kairatov is a Biopharma expert with extensive knowledge in technology and innovation within the industry and considerable experience in research and development. Today, we discuss the newly introduced Genomic Data Protection Act (GDPA) and its implications. Can you explain the main purpose of

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that significantly impacts both liver and lung function, resulting in a rare but severe health burden. In an ambitious and promising development, Prime Medicine is leveraging its innovative gene editing technology to address this

The discovery of a nematode, known as Panagrolaimus kolymaensis, unearthed from the depths of the Siberian permafrost has astonished scientists. This microscopic worm managed to survive in a state of cryptobiosis for an astounding 46,000 years. Over this period, it remained suspended in a

In this interview, we are pleased to welcome Ivan Kairatov, a Biopharma expert with deep knowledge of tech and innovation in the industry and extensive experience in research and development, particularly in gene therapy for sensory disorders. Today, Ivan will share insights on the recent positive

Human aging is a complex process influenced by a combination of genetic and environmental factors. While the role of genetics has been widely studied, recent research highlights the significant impact of environmental exposures on aging and premature mortality. This article delves into the findings

Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. Can you tell us a little about your professional background and your role as a biopharma expert? Certainly. I have spent the last couple of decades working at